Graves' Disease & Thyroid Foundation

The Graves’ Disease & Thyroid Foundation provides educational and support services for patients with Graves’ disease, thyroid eye disease & related disorders.

[Graves' Disease & Thyroid Foundation @GDATF]

Patients with thyroid eye disease often rely on OTC eye drops for symptom relief, but it seems like there's a new recall in the news every other month. If you have concerns about what's in your medicine cabinet, check out https://t.co/WafUW1Lw1d, a project of the @dry_eye_fdn.

[Graves' Disease & Thyroid Foundation @GDATF]

Science can move "gradually, then suddenly"! Just days after we attended the ASOPRS Fall Symposium - which included talks on the SatraGO-1 and SatraGO-2 trials - the FDA has approved Enspryng as the first subcutaneous treatment for thyroid eye disease. https://t.co/8WCBtYy6yg

[Graves' Disease & Thyroid Foundation @GDATF]

If you are attending the #ASOPRS Fall Scientific Symposium in New Orleans, stop by booth #103 in the exhibit hall and say hello!

[Graves' Disease & Thyroid Foundation @GDATF]

USA-based Graves' patients: the GDATF wants to hear from you! As a final step before sharing our survey results, we'll be hosting three focus groups in October, and we'd be honored if you would participate! More info here: https://t.co/CVvcDBPjOV

[Graves' Disease & Thyroid Foundation @GDATF]

THANK YOU to the 400+ patients who took the time to complete our Graves' survey. If you are curious how we share survey data, check out this page from our website with highlights from our 2022 TED survey. https://t.co/p2gNf2WUr7

[Graves' Disease & Thyroid Foundation @GDATF]

If you forgot about our survey for USA-based Graves' patients, you still have until midnight to participate! The survey takes about 20 minutes, and once you complete the screening questions, you can save your place and come back: https://t.co/VIhFe0B2b3

[Graves' Disease & Thyroid Foundation @GDATF]

REMINDER: Survey closes at the end of the day on Tuesday! Get started here: https://t.co/VIhFe0Aulv

[Graves' Disease & Thyroid Foundation @GDATF]

Our Graves' survey for USA-based patients has been extended to Sep. 15th - we'd be honored if you would participate! Check out this video from Exec Director Kimberly Dorris for survey tips & insight on how we use survey data - or jump into the survey here: https://t.co/5yapjDhiL9

[Graves' Disease & Thyroid Foundation @GDATF]

Our survey for USA-based Graves' patients closes in 3 days. We'd be grateful if you could take 20 minutes to share your experience! https://t.co/VIhFe0Aulv

[Graves' Disease & Thyroid Foundation @GDATF]

FIVE days until our survey for USA-based patients closes. Please take 20 minutes to make your voice heard! https://t.co/VIhFe0Aulv

[Graves' Disease & Thyroid Foundation @GDATF]

SIX days until our survey closes! We'd be grateful if our USA-based Graves' Queens (and Kings) could take 20 minutes to complete our patient survey by Sept. 15th! https://t.co/VIhFe0Aulv

[American Thyroid Association @AmThyroidAssn]

The countdown is on—less than 2 months until the #atathyroid2026 Annual Meeting in Philadelphia, November 4–7! Preview what’s in store: https://t.co/vOtJmwBwzx. Come for the meeting & stay for the Philly! #americanthyroidassociation #ThyroidEducation @AmThyroidAssn

[Graves' Disease & Thyroid Foundation @GDATF]

If you have 20 minutes of down time this holiday weekend, we'd be honored if you would take our survey for USA-based Graves' patients. Make your voice heard! https://t.co/TkWCu0Pmyg

[Graves' Disease & Thyroid Foundation @GDATF]

Our Graves' survey for USA-based patients has been extended to Sep. 15th - we'd be honored if you would participate! Check out this video from Exec Director Kimberly Dorris for survey tips & insight on how we use survey data - or jump into the survey here: https://t.co/5yapjDhiL9

[Graves' Disease & Thyroid Foundation @GDATF]

Your Feedback Matters - Survey Extended to Sept. 15th! https://t.co/LYcxvcTuPS via @YouTube

[Graves' Disease & Thyroid Foundation @GDATF]

Our Graves' patient survey has been extended to Sept. 15th! If you don't have 20 minutes to complete the survey in one sitting, you can save your place and come back! Get started here: https://t.co/TkWCu0Pmyg

[Graves' Disease & Thyroid Foundation @GDATF]

Curiouser and curiouser: the company has ceased operations permanently: https://t.co/jgPmgwovKm

[Graves' Disease & Thyroid Foundation @GDATF]

Another thyroid medication recall - this one for a desiccated thyroid extract product from Vitruvias Therapeutics that is potentially "superpotent" (contains too much active ingredient). This link from the FDA has more info & a photo of the product label: https://t.co/FxIDywjp0y

[Clinical Thyroidology @clinicalthyroid]

Read/download expert reviews in the June issue covering the latest in Clinical #Thyroid.

https://t.co/DNg4TL0qaB

#endotwitter #medtwitter #thyroidcancer #hypothyroidism #hyperthyroidism #Hashimotos #thyroiditis #iodine @ThyCaInc @GDATF @Medscape @EndocrineToday

[Graves' Disease & Thyroid Foundation @GDATF]

Our Graves' patient survey has been extended to Sept. 15th! If you don't have 20 minutes to complete the survey in one sitting, you can save your place and come back! Get started here: https://t.co/TkWCu0Pmyg

[European Thyroid Journal @Eur_Thyroid_J]

New Consensus Statement

Developed by an expert panel nominated by @ETA_Thyroid, @ThyroidBritish, Society for Endocrinology & @welshendodiab , this document brings together current evidence & expert consensus to support the management of thyroid storm.

🔗https://t.co/UNeJ7FF82F